“Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Positive Mutations”, Indian Journal of Forensic Medicine & Toxicology, vol. 15, no. 3, pp. 4316–4324, May 2021, doi: 10.37506/ijfmt.v15i3.15970.